Recent advances in otitis media

Pediatric Infectious Disease Journal

Volumn 28, Issue 10 SUPPL., 2009, Pages

  Pelton, Stephen I ^a,c   Leibovitz, Eugene ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c BOSTON MEDICAL CENTER   (United States)

Author keywords

Acute otitis media; Antibacterials; Antibiotherapy; Early onset; Management; Middle ear fluid; Nasopharyngeal colonization; Otopathogens; Persistent otitis media; Prevention; Recurrent otitis media; Upper respiratory tract infection; Watchful waiting strategy

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFACLOR; CEFDINIR; CEFTRIAXONE; CEFUROXIME AXETIL; COTRIMOXAZOLE; GATIFLOXACIN; LEVOFLOXACIN; PNEUMOCOCCUS VACCINE;

ACUTE OTITIS MEDIA; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; BACTERIAL COLONIZATION; CLINICAL TRIAL; DRUG EFFICACY; DRUG MEGADOSE; DRUG TREATMENT FAILURE; HAEMOPHILUS INFLUENZAE; HUMAN; MORAXELLA CATARRHALIS; MYRINGOTOMY; NASOPHARYNX; NONHUMAN; OTITIS MEDIA; PATHOGENESIS; PNEUMOCOCCAL INFECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; STREPTOCOCCUS PNEUMONIAE; UPPER RESPIRATORY TRACT INFECTION;

EID: 70350448858     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181b6d81a     Document Type: Article

References (35)

1. Rovers MM. The burden of otitis media. Vaccine. 2008; 26(suppl 7):G2-G4.
2. Greenberg D, Bilenko N, Liss Z, et al. The burden of acute otitis media on the patient and the family. Eur J Pediatr. 2003;162:576-581.
3. Murphy TF, Bakaletz LO, Kyd JM, et al. Vaccines for otitis media: proposals for overcoming obstacles to progress. Vaccine. 2005; 23:2696-2702.
4. Berman S. Otitis media in developing countries. Pediatrics. 1995; 96:126-131.
5. WHO. Chronic suppurative otitis media: burden of illness and management options. Geneva, Switzerland: WHO; 2004.
6. Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis. 1989; 160:83-94.
7. Corbeel L. What is new in otitis media? Eur J Pediatr. 2007; 166:511-519.
8. Paradise JL, Rockette HE, Colborn DK, et al. Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics. 1997; 99:318-333.
9. Leach AJ. Otitis media in Australian Aboriginal children: an overview. Int J Pediatr Otorhinolaryngol. 1999; 49(suppl 1):S173-S178.
10. Morris PS, Leach AJ, Halpin S, et al. An overview of acute otitis media in Australian Aboriginal children living in remote communities. Vaccine. 2007; 25:2389-2393.
11. Bluestone CD. Pathogenesis of otitis media: role of Eustachian tube. Pediatr Infect Dis J. 1996; 15:281-291.
12. Bluestone CD, Hebda PA, Alper CM, et al. Recent advances in otitis media. 2. Eustachian tube, middle ear, and mastoid anatomy; physiology, pathophysiology, and pathogenesis. Ann Otol Rhinol Laryngol Suppl. 2005; 194: 16-30.
13. Siegrist CA. The challenges of vaccine responses in early life: selected examples. J Comp Pathol. 2007; 137(suppl 1):S4-S9.
14. Faden H, Duffy L, Wasielewski R, et al. Relationship between nasopharyngeal colonization and the development of otitis media in children. Tonawanda/Williamsville Pediatrics. J Infect Dis. 1997; 175:1440-1445.
15. Chonmaitree T, Revai K, Grady JJ, et al. Viral upper respiratory tract infection and otitis media complication in young children. Clin Infect Dis. 2008; 46:815-823.
16. Revai K, Mamidi D, Chonmaitree T. Association of nasopharyngeal bacterial colonization during upper respiratory tract infection and the development of acute otitis media. Clin Infect Dis. 2008; 46:e34-e37.
17. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001; 344:403-409.
18. Giebink GS, Meier JD, Quartey MK, et al. Immunogenicity and efficacy of Streptococcus pneumoniae polysaccharide-protein conjugate vaccines against homologous and heterologous serotypes in the chinchilla otitis media model. J Infect Dis. 1996; 173:119-127.
19. Jokinen JT, Ahman H, Kilpi TM, et al. Concentration of antipneumococcal antibodies as a serological correlate of protection: an application to acute otitis media. J Infect Dis. 2004; 190:545-550.
20. Fireman B, Black SB, Shinefield HR, et al. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J. 2003; 22:10-16.
21. Grijalva CG, Poehling KA, Nuorti JP, et al. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics. 2006; 118:865-873.
22. Zhou F, Shefer A, Kong Y, Nuorti JP. Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004. Pediatrics. 2008; 121:253-260.
23. Plasschaert AI, Rovers MM, Schilder AG, et al. Trends in doctor consultations, antibiotic prescription, and specialist referrals for otitis media in children: 1995-2003. Pediatrics. 2006; 117:1879-1886.
24. Poehling KA, Szilagyi PG, Grijalva CG, et al. Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine. Pediatrics. 2007; 119:707-715.
25. Dagan R, Leibovitz E. Bacterial eradication in the treatment of otitis media. Lancet Infect Dis. 2002; 2:593-604.
26. Dagan R, Schneider S, Givon-Lavi N, et al. Failure to achieve early bacterial eradication increases clinical failure rate in acute otitis media in young children. Pediatr Infect Dis J. 2008; 27:200-206.
27. Howie VM, Ploussard JH. Efficacy of fixed combination antibiotics versus separate components in otitis media. Effectiveness of erythromycin estrolate, triple sulfonamide, ampicillin, erythromycin estolate- triple sulfonamide, and placebo in 280 patients with acute otitis media under two and one-half years of age. Clin Pediatr (Philo). 1972; 11:205-214.
28. Marchant C, Dagan R. Bacteriologic efficacy of antimicrobial agents. In: Rosenfeld R, Bluestone C, eds. Evidence-Based Otitis Media. 2nd ed. Hamilton, Ontario, Canada: BC Decker; 2003:256-267.
29. Leibovitz E. The challenge of recalcitrant acute otitis media: pathogens, resistance, and treatment strategy. Pediatr Infect Dis J. 2007; 26:S8-S11.
30. Leibovitz E, Raiz S, Piglansky L, et al. Resistance pattern of middle ear fluid isolates in acute otitis media recently treated with antibiotics. Pediatr Infect Dis J. 1998; 17:463-469.
31. Klein JO, Teele DW, Pelton SI. New concepts in otitis media: results of investigations of the Greater Boston Otitis Media Study Group. Adv Pediatr. 1992; 39:127-156.
32. Leibovitz E, Greenberg D, Piglansky L, et al. Recurrent acute otitis media occurring within one month from completion of antibiotic therapy: relationship to the original pathogen. Pediatr Infect Dis J. 2003; 22:209-216.
33. Libson S, Dagan R, Greenberg D, et al. Nasopharyngeal carriage of Streptococcus pneumoniae at the completion of successful antibiotic treatment of acute otitis media predisposes to early clinical recurrence. J Infect Dis. 2005; 191:1869-1875.
34. Asher E, Dagan R, Greenberg D, et al. Persistence of pathogens despite clinical improvement in antibiotic-treated acute otitis media is associated with clinical and bacteriologic relapse. Pediatr Infect Dis J. 2008; 27:296-301.
35. American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics. 2004; 113:1451-1465.